Zubin J Eapen
Overview
Explore the profile of Zubin J Eapen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hummel J, Houmsse M, Tomassoni G, Nair D, Romero J, Hargrove J, et al.
J Am Coll Cardiol
. 2024 Jul;
84(6):525-536.
PMID: 39084827
Background: For many patients, sudden cardiac arrest (SCA) risk is elevated temporarily. Wearable cardioverter-defibrillators (WCDs) can monitor and treat SCA during these temporary periods. Traditional WCDs can be uncomfortable, require...
2.
Chovanec M, Petru J, Hala P, Kralovec S, Thakkar A, Mathews K, et al.
Europace
. 2024 Jul;
26(7).
PMID: 39001864
Aims: Wearable cardioverter-defibrillators (WCDs) are indicated in patients at risk of sudden cardiac arrest who are not immediate candidates for implantable defibrillator therapy. Limitations of existing WCDs include poor compliance...
3.
Nelson A, Ardissino M, Haynes K, Shambhu S, Eapen Z, McGuire D, et al.
J Am Heart Assoc
. 2021 Jan;
10(2):e016835.
PMID: 33432843
Background Evidence-based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Methods and Results Pharmacy...
4.
Loungani R, Teerlink J, Metra M, Allen L, Butler J, Carson P, et al.
JACC Heart Fail
. 2020 Nov;
8(12):999-1008.
PMID: 33189635
Objectives: This study sought to better understand the discrepant results of 2 trials of serelaxin on acute heart failure (AHF) and short-term mortality after AHF by analyzing causes of death...
5.
Sharma A, Harrington R, McClellan M, Turakhia M, Eapen Z, Steinhubl S, et al.
J Am Coll Cardiol
. 2018 Jun;
71(23):2680-2690.
PMID: 29880129
As we enter the information age of health care, digital health technologies offer significant opportunities to optimize both clinical care delivery and clinical research. Despite their potential, the use of...
6.
Chang L, DeVore A, Granger B, Eapen Z, Ariely D, Hernandez A
Circulation
. 2017 Aug;
136(8):765-772.
PMID: 28827221
Behavioral challenges are often present in human illness, so behavioral economics is increasingly being applied in healthcare settings to better understand why patients choose healthy or unhealthy behaviors. The application...
7.
Blood A, Fraiche A, Eapen Z
Prog Cardiovasc Dis
. 2017 Jul;
60(2):171-177.
PMID: 28733079
Given the high prevalence of heart failure (HF) and the profound impact on morbid, mortality, and health care costs, strategies to improve outcomes and reduce cost have become progressively more...
8.
Eapen Z, Mi X, Fonarow G, Setoguchi S, Piccini J, Mills R, et al.
J Atr Fibrillation
. 2017 May;
6(4):953.
PMID: 28496911
The risks and benefits of anticoagulation for patients with both heart failure and atrial fibrillation are unclear. We hypothesized that anticoagulation was associated with improved clinical outcomes of heart failure...
9.
Zsilinszka R, Mentz R, DeVore A, Eapen Z, Pang P, Hernandez A
JACC Heart Fail
. 2017 Mar;
5(5):329-336.
PMID: 28285117
Acute heart failure (HF) is a major public health problem with substantial associated economic costs. Because most patients who present to hospitals are admitted irrespective of their level of risk,...
10.
Fraiche A, Eapen Z, McClellan M
JACC Heart Fail
. 2017 Feb;
5(4):297-304.
PMID: 28189579
Telehealth offers an innovative approach to improve heart failure care that expands beyond traditional management strategies. Yet the use of telehealth in heart failure is infrequent because of several obstacles....